BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2722856)

  • 1. Antithrombin III-dependent anti-prothrombinase activity of heparin and heparin fragments.
    Schoen P; Lindhout T; Willems G; Hemker HC
    J Biol Chem; 1989 Jun; 264(17):10002-7. PubMed ID: 2722856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothrombin protects factor Xa in the prothrombinase complex from inhibition by the heparin-antithrombin complex.
    Rezaie AR
    Blood; 2001 Apr; 97(8):2308-13. PubMed ID: 11290592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in situ inhibition of prothrombinase-formed human alpha-thrombin and meizothrombin(des F1) by antithrombin III and heparin.
    Schoen P; Lindhout T
    J Biol Chem; 1987 Aug; 262(23):11268-74. PubMed ID: 3611110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin generation and inactivation in the presence of antithrombin III and heparin.
    Lindhout T; Baruch D; Schoen P; Franssen J; Hemker HC
    Biochemistry; 1986 Oct; 25(20):5962-9. PubMed ID: 3790498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of prothrombinase by antithrombin-heparin at a macroscopic surface.
    Speijer H; Billy D; Willems G; Hemker HC; Lindhout T
    Thromb Haemost; 1995 Apr; 73(4):648-53. PubMed ID: 7495073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow and the inhibition of prothrombinase by antithrombin III and heparin.
    Schoen P; Lindhout T
    Blood; 1991 Jul; 78(1):118-24. PubMed ID: 2070046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Characterization of assembly, product formation, and heparin dissociation steps in the factor Xa reaction.
    Craig PA; Olson ST; Shore JD
    J Biol Chem; 1989 Apr; 264(10):5452-61. PubMed ID: 2925612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
    Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
    Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of intrinsic prothrombinase and its generation by heparin and four derivatives in prothrombin poor plasma.
    Bendetowicz AV; Bara L; Samama MM
    Thromb Res; 1990 Jun; 58(5):445-54. PubMed ID: 2164262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor Xa is highly protected from antithrombin-fondaparinux and antithrombin-enoxaparin when incorporated into the prothrombinase complex.
    Brufatto N; Ward A; Nesheim ME
    J Thromb Haemost; 2003 Jun; 1(6):1258-63. PubMed ID: 12871328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of inhibition of the prothrombinase complex by a covalent antithrombin-heparin complex.
    Stevic I; Berry LR; Chan AK
    J Biochem; 2012 Aug; 152(2):139-48. PubMed ID: 22518847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation.
    Pieters J; Willems G; Hemker HC; Lindhout T
    J Biol Chem; 1988 Oct; 263(30):15313-8. PubMed ID: 3262615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DX-9065a inhibition of factor Xa and the prothrombinase complex: mechanism of inhibition and comparison with therapeutic heparins.
    Rezaie AR
    Thromb Haemost; 2003 Jan; 89(1):112-21. PubMed ID: 12540961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acceleration of the inhibition of platelet prothrombinase complex by heparin.
    Ellis V; Scully MF; Kakkar VV
    Biochem J; 1986 Jan; 233(1):161-5. PubMed ID: 3954724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.
    Lane DA; Denton J; Flynn AM; Thunberg L; Lindahl U
    Biochem J; 1984 Mar; 218(3):725-32. PubMed ID: 6721831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
    Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
    J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.
    Ofosu FA; Hirsh J; Esmon CT; Modi GJ; Smith LM; Anvari N; Buchanan MR; Fenton JW; Blajchman MA
    Biochem J; 1989 Jan; 257(1):143-50. PubMed ID: 2920007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative molecular mass dependence of the anti-factor Xa properties of heparin.
    Ellis V; Scully MF; Kakkar VV
    Biochem J; 1986 Sep; 238(2):329-33. PubMed ID: 3800942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of prothrombinase at macroscopic lipid membranes: competition between antithrombin and prothrombin.
    Billy D; Speijer H; Lindhout T; Hemker HC; Willems GM
    Biochemistry; 1995 Oct; 34(41):13699-704. PubMed ID: 7577961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.